Additional Release Notes: Caristix v2.8
December 5, 2013
Information for Cloak and Workgroup Users With our recent v2.8 update, we made the default de-identification rules more robust. You’ll need to add fewer rules
Information for Cloak and Workgroup Users With our recent v2.8 update, we made the default de-identification rules more robust. You’ll need to add fewer rules
Here’s how it starts: Are HL7 interfaces becoming more important or less important with the push for interoperability and the popularity of integrated hospital systems?
This dot release contains several new features and enhancement requests. Caristix Users To access v2.8, simply go to the Help menu, and click Check for
Message Player, our free HL7 listener/router utility designed for HIT software developers, interface developers, and interface analysts, is now out. You might have seen other
Wishing you a wonderful holiday season and New Year!
We’re happy to announce that Caristix has made the list of Top 25 Up and Comers among Canadian ICT companies. Check out the Top 25
If you’re going to be at Interconnected Health 2012 (April 2-4) in Chicago, check out the session with Jean-Luc Morin, VP R&D here at Caristix.
Agent de support au service technique Nous ouvrons un poste, basé à Québec, pour notre nouveau service technique. Les responsabilités de notre unité technique sont
Technical Support Rep We’re looking for a full-time, Quebec City-based support rep. This isn’t your typical tech and/or sales support position. We’re seeking one very
Stéphane Vigot, Caristix co-founder and president, is presenting today at the International Startup Festival, a new conference on the business of startups. He’ll be pitching
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.